Bayram,, Fahri, Tanriverdi,, Fatih, Kurtoglu,, Selim, Atabek,, M. Emre, Kula,, Mustafa, Kaynar,, Leyla and Keleştimur,, Fahrettin. "Effects of 3 Years of Intravenous Pamidronate Treatment on Bone Markers and Bone Mineral Density in a Patient with Osteoporosis-Pseudoglioma Syndrome (OPPG)"
Journal of Pediatric Endocrinology and Metabolism, vol. 19, no. 3, 2006, pp. 275-280.
https://doi.org/10.1515/JPEM.2006.19.3.275Bayram,, F., Tanriverdi,, F., Kurtoglu,, S., Atabek,, M., Kula,, M., Kaynar,, L. & Keleştimur,, F. (2006). Effects of 3 Years of Intravenous Pamidronate Treatment on Bone Markers and Bone Mineral Density in a Patient with Osteoporosis-Pseudoglioma Syndrome (OPPG).
Journal of Pediatric Endocrinology and Metabolism,
19(3), 275-280.
https://doi.org/10.1515/JPEM.2006.19.3.275Bayram,, F., Tanriverdi,, F., Kurtoglu,, S., Atabek,, M., Kula,, M., Kaynar,, L. and Keleştimur,, F. (2006) Effects of 3 Years of Intravenous Pamidronate Treatment on Bone Markers and Bone Mineral Density in a Patient with Osteoporosis-Pseudoglioma Syndrome (OPPG). Journal of Pediatric Endocrinology and Metabolism, Vol. 19 (Issue 3), pp. 275-280.
https://doi.org/10.1515/JPEM.2006.19.3.275Bayram,, Fahri, Tanriverdi,, Fatih, Kurtoglu,, Selim, Atabek,, M. Emre, Kula,, Mustafa, Kaynar,, Leyla and Keleştimur,, Fahrettin. "Effects of 3 Years of Intravenous Pamidronate Treatment on Bone Markers and Bone Mineral Density in a Patient with Osteoporosis-Pseudoglioma Syndrome (OPPG)"
Journal of Pediatric Endocrinology and Metabolism 19, no. 3 (2006): 275-280.
https://doi.org/10.1515/JPEM.2006.19.3.275Bayram, F, Tanriverdi, F, Kurtoglu, S, Atabek, M, Kula, M, Kaynar, L, Keleştimur, F. Effects of 3 Years of Intravenous Pamidronate Treatment on Bone Markers and Bone Mineral Density in a Patient with Osteoporosis-Pseudoglioma Syndrome (OPPG).
Journal of Pediatric Endocrinology and Metabolism. 2006;19(3): 275-280.
https://doi.org/10.1515/JPEM.2006.19.3.275Copied to clipboard
